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7.6; 37% female, 63% male) participated in a health examination which included a 
lipid proﬁ le. An index date was assigned for each study participant using the date of 
their exam and statin medication usage was determined through the pharmacy claims 
database for 365 days before the index date. Patients were identiﬁ ed as adherent to 
statins if their medication possession ratio (MPR) was at least 80%. RESULTS: Statin
use increased over the study period with 150 (9.3%) executives ﬁ lling at least one 
statin prescription in the 365 days prior to their exam. A total of 102 statin users
(68%) were adherent to statin medication. Among all patients who received statin 
treatment, 70% (OR  2.33, 95% CI  1.54, 3.51) achieved near optimal ( 130 mg/
dL) and 30% (OR  1.78, 95% CI  1.15, 2.76) achieved optimal ( 100 mg/dL)
LDL-C goals which are signiﬁ cantly higher than the rates among statin non-users 
(55% and 21%). Both adherent statin users and nonadherent statin users were more 
likely to achieve recommended near optimal LDL-C goals compared to executives who
were not taking statins (overall p  0.002; adherent: OR  2.75, 95%CI 1.662, 4.550; 
nonadherent: OR  1.70, 95% CI 0.884, 3.268.) CONCLUSIONS: Among executives
who participated in a periodic health examination, statin usage appears to be associ-
ated with improvements in LDL-C goal attainment. Appropriate medication usage and 
adherence to medication should be encouraged in working populations.
PC+4V19
EFFECT OF ACE INHIBITORS/ARBS AND STATINS ON THE INCIDENCE
OF DEMENTIA, IN PATIENTS WITH CHRONIC HEART FAILURE
Agarwal SJ, Johnson ML
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OBJECTIVES: To determine the effect of ACE Inhibitors/ARBs and statins on the
incidence of dementia, in patients with Chronic Heart Failure (CHF). METHODS:
A national retrospective cohort of Veterans Affairs (VA) patients, with at least 
one outpatient claim of CHF from October 1, 1996 to September 30, 2000,
was identiﬁ ed. Drug exposure was analyzed from October 1, 1998 to September
30, 2000 and outcome of dementia (yes/no) was identiﬁ ed, based on ICD-9-CM
codes, from October 1, 2000 to September 1, 2002. Patients with non-utilization of 
VA services for two years and prevalent cases of dementia were excluded. A Cox
proportional hazards model of time to dementia diagnosis was constructed to test the
association of drug use with dementia, adjusted for socio-demographics, co-morbidi-
ties and co-medications. RESULTS: Out of 242,734 patients, 2.77% developed 
dementia during follow-up. About 75% were elderly and 79% had hypertension. 
Females, African-Americans had signiﬁ cantly higher risk of dementia than males, 
whites, respectively. Risk of dementia increased progressively with age. In adjusted 
analyses, hypertension (HR: 1.157, 95% CI: 1.078–1.240), diabetes (HR: 1.105, 95% 
CI: 1.051–1.161), and cerebrovascular disease (HR: 1.577, 95% CI: 1.489–1.671) 
signiﬁ cantly increased risk of dementia. Adjusted analyses of one-year (HR: 0.988, 
95% CI: 0.911–1.071) or two-year (HR: 0.991, 95% CI: 0.930–1.057) exposure 
to ACE Inhibitors did not signiﬁ cantly affect dementia. Adjusted analyses of one-
year exposure to ARBs (HR: 0.784, 95% CI: 0.634–0.969), statins (HR: 0.906, 
95% CI: 0.839–0.979) and two-year exposure to ARBs (HR: 0.711, 95% CI: 
0.594–0.852), statins (HR: 0.884, 95% CI: 0.829–0.943) had protective effect on
incidence of dementia. Two-year drug exposure had increased protective effect, com-
pared to one-year exposure. CONCLUSIONS: Study suggests potential beneﬁ cial 
effects, to delay onset of dementia, associated with use of ARBs and statins. Thus, 
prescribing of such agents in pharmacotherapeutic regimens of CHF patients should 
be encouraged.
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OBJECTIVES: Coronary heart disease (CHD) is a major health issue in Hong Kong
and has become the second leading cause of death since the 1960s. Figures from the 
Hong Kong Department of Health Statistics have shown that in the year 2005, 
approximately 11 persons died from CHD each day. The prevalence of CHD and its
mortality in Hong Kong are approaching a level that requires focused attention.
Unfortunately, CHD could be a silent disease until the manifestations occur. Therefore, 
early detection and control of cardiovascular risk factors including cholesterol and
blood pressure is vital. In view of this point, the current project aimed to investigate 
the 10-year cardiovascular risk in the general public of Hong Kong. METHODS: A
12-month prospective public screening of lipid panels and blood pressure for the esti-
mation of 10-year cardiovascular risk was conducted in the general public of Hong 
Kong between April 2007 and April 2008. RESULTS: During this period, a total of 
2,607 patients were recruited with the mean age of 46.4/11.1 years old (51.3%
male) and 8.1% of subjects were active smokers. Among all of the subjects, the mean
total cholesterol was 5.42/1.28 mmol/L and the mean high density cholesterol was
1.59/0.75 mmol/L. The mean systolic blood pressure was 121.7/19.5 mmHg. The
assessment of the 10-year cardiovascular risk showed that 13.8% of the subjects were
moderately high to high risk patients. CONCLUSIONS: The project demonstrated
that the general public in Hong Kong had relatively high total cholesterol and normal-
high systolic blood pressure. There were almost 2 in every 10 Hong Kong citizens may
have a 10–20% or more than 20% risk to develop CHD in the next 10 years. As a 
result, good lifestyle modiﬁ cation and regular health screening are essential and 
urgently required to lower the cardiovascular risk in the general public of Hong 
Kong.
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OBJECTIVES: National estimates of cardiovascular risk factor prevalence, awareness, 
treatment, and control among adults without health insurance are lacking. This study 
contributes to our knowledge by examining current national estimates for hyperten-
sion, dyslipidemia, and diabetes among uninsured, non-Medicaid insured, and 
Medicaid-insured adults aged 18 through 64 years. METHODS: Cross-sectional
observational study design. Analysis of adults 18 through 64 years of age surveyed in 
the National Health and Nutrition Examination Survey (NHANES) 2003–2006 (N 
8,500). RESULTS: Of an estimated 178.6 million working-age adults, 21.8% (95%
conﬁ dence interval [CI]  19.6%– 24.1%) lack health insurance. Hypertension preva-
lence is signiﬁ cantly lower in the uninsured compared with the non-Medicaid insured 
(18.9% and 21.8%, age and gender adjusted) as are rates of awareness (62.8% vs 
77.0%) and treatment (43.9% vs 65.5%). Medicaid-insured adults have a signiﬁ cantly 
higher prevalence of hypertension (29.1%) than the non-Medicaid insured. There is
no signiﬁ cant difference between the uninsured and non-Medicaid insured with respect
to adjusted prevalence of dyslipidemia (27.4% and 25.3%) or type-2 diabetes (6.4%
and 6.0%). Awareness and treatment rates for dyslipidemia are signiﬁ cantly lower in
the uninsured compared with the non-Medicaid insured (38.8% vs 64.7% for aware-
ness; 18.0% vs 41.4% for treatment). Treatment rates for diabetes are also signiﬁ -
cantly lower for the uninsured (39.9% vs 62.5%). Multivariable logistic regression
controlling for age, gender, race, education, access to care, and marital status indicate
that the uninsured are signiﬁ cantly less likely than the non-Medicaid insured to be 
aware of and treated for their dyslipidemia and less likely to be treated for their dia-
betes. CONCLUSIONS: Dyslipidemia and diabetes are less likely to be detected or 
treated among the uninsured compared with the non-Medicaid insured, calling for 
effective approaches to reduce these disparities.
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OBJECTIVES: The purpose of this study was to examine whether there is a difference 
in the seasonal, weekly and daily variation of acute myocardial infarction in patients
who were diabetic and who were not, and to get information about the mechanism 
of the background of the rhythm variation and about the triggering effects. METHODS:
Retrospective analysis was made with acute myocardial infarction patients received in
almost all hospitals in Hungary between 2005 and 2007 (n  41.510, 23.993 male, 
17.517 female). Data were collected from the database of the National Health Insur-
ance Fund Administration based on ICD codes: I21, I22, E1000–1490. RESULTS:
With regard to seasonal variation, the peek period of acute myocardial infarction was
found during the months of spring, the lowest number of events is during the summer.
There was a signiﬁ cant difference between the number of events for each season (p 
0.003). The weekly peek period of acute myocardial infarction was found on the ﬁ rst
day of the week, on Monday, with a gradually decreasing tendency towards the end 
of the week, until Sunday. The decrease is much higher in the weekend. Regarding the 
daily rhythm, the results were signiﬁ cant. The peek period was found in the morning
hours of the day, and the lowest number of acute myocardial infarction was in the 
evening hours (p  0,001). In case of patients with diabetes (5.739 male, 5.376 female) 
the results were similar, the seasonal variation in the occurrence of acute myocardial 
infarction is also signiﬁ cant, such as the results of the weekly and daily rhythm (p 
0.025, p  0.000). CONCLUSIONS: In summary, it can be said that the results of our 
study show that the incidence of an acute myocardial infarction shows characteristic 
variation with regard to seasons and the days of the week, but there are no differences 
between diabetic and non-diabetic patients.
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OBJECTIVES: The purpose of our study was to observe whether a seasonal change
or weekly variation can be shown in the incidence of an acute myocardial infarction 
(AMI) and a transient ischemic attack (TIA) during a three-year study period in 
Hungary. We also examined whether the occurrence of an AMI or a TIA is inﬂ uenced
by age and sex. METHODS: We have analyzed AMI (N  51,802) and TIA (N 
12,592) patients received at clinics and hospitals in Hungary between 2005 and 2007.
Data were collected from the database of the National Social Security Fund (OEP) 
based on the International Classiﬁ cation of Diseases (ICD codes). RESULTS: Based 
on our results, a weekly and a seasonal variation can be seen in the onset of a transient 
ischemic attack and an acute myocardial infarction. With regard to seasonal variation, 
there was a signiﬁ cant difference between the number of events for each season (p 
0.01), and the peek period of AMI and TIA was found during the months of spring, 
the lowest number of events of AMI is during the summer and in the case of TIA is 
in autumn. In case of sexes, difference was only found in the seasonal variation of 
number of events of AMI (p  0.01). The weekly peek period of infarction and cerebral 
